Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-208
Closed -$12K 3198
2022
Q3
$12K Sell
208
-34
-14% -$2.3K ﹤0.01% 2528
2022
Q2
$10K Sell
242
-14
-5% -$838 ﹤0.01% 2683
2022
Q1
$26K Buy
+256
New +$29.2K ﹤0.01% 2806
2021
Q4
Sell
-1,132
Closed -$312K 4134
2021
Q3
$312K Sell
1,132
-102
-8% -$33.7K ﹤0.01% 2380
2021
Q2
$474K Sell
1,234
-373
-23% -$113K ﹤0.01% 1830
2021
Q1
$188K Buy
1,607
+1,456
+964% +$174K ﹤0.01% 2327
2020
Q4
$13K Sell
151
-1,164
-89% -$130K ﹤0.01% 1754
2020
Q3
$114K Buy
1,315
+846
+180% +$101K ﹤0.01% 1497
2020
Q2
$67K Buy
469
+356
+315% +$53.3K ﹤0.01% 1293
2020
Q1
$17K Sell
113
-74
-40% -$15.2K ﹤0.01% 678
2019
Q4
$42K Sell
187
-97
-34% -$26.2K ﹤0.01% 1073
2019
Q3
$69K Buy
+284
New +$72.7K ﹤0.01% 1281

Other funds holding UXIN

HRT Financial's UXIN Position: Q4 2022 in Review

HRT Financial sold out of Uxin Ltd (UXIN) in Q4 2022, closing a stake of 208 shares — an estimated $12K sold.

HRT Financial first reported a position in UXIN in Q3 2019 and held it in 12 quarters. The position peaked at $474K in Q2 2021. 21 funds tracked by Wall St. Rank hold UXIN as of Q4 2022.

  • HRT Financial reported no remaining Uxin Ltd position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 208 Uxin Ltd shares in Q4 2022, an estimated $12K.
  • HRT Financial first reported a position in Uxin Ltd in Q3 2019 and held it in 12 quarters.
  • HRT Financial's Uxin Ltd position peaked at $474K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Uxin Ltd as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.